InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,466.64
(
-0.05%
)
US TECH 100
19,185.60
(
0.05%
)
Dow Jones
39,038.03
(
-0.19%
)
Brent Oil
84.17
(
-0.02%
)
Bitcoin
61,804.80
(
-0.01%
)
Post# of 252361
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: DewDiligence post# 210622

Friday, 04/14/2017 12:40:53 PM

Friday, April 14, 2017 12:40:53 PM

Post# of 252361
LLY/INCY:

LLY/INCY have a lot of work ahead to get Baricitinib approved



Agree. It's surprising, but those "issues" are basically the same ones you have at the beginning of a phase I trial.

Further surprising because despite the breadth of the FDA's concerns, the EMEA approved. Very curious to know what the issue is, but I suspect we won't know until / if a follow-up trial protocol shows up.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up